Glutenase enzyme assays
US7534426B2 · kind B2 · utility
23Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2005 |
| Grant date | May 19, 2009 |
| Priority date | — |
| Expiry date | Jan 15, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/482
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.